Edward J. Dulac III, EVP, CFO: Intellia Therapeutics NTLA Sell · Filed 25/07/25

Trade details

Type: Insider sale
Amount: $104,617.24
Shares · price: 7,462 sh · $14.02 a share
Held after: 106,062 sh
Stock: Intellia Therapeutics NTLA
Person: Edward J. Dulac IIIEVP, CFO
Trade date: 25/07/23
Filed: 25/07/25
Days to filing: 2 days

Sold 6.6% of holdings

Share of holding sold: 6.6%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/23~25/08/22

Edward J. Dulac III's recent trades

Edward J. Dulac IIIEVP, CFO
Planned sale10b5-1 planIntellia Therapeutics
Planned sale10b5-1 plan
Intellia Therapeutics
NTLA
$80.6K
4,677 sh
$80.6K
Filed 07/02
Traded 07/02
Edward J. Dulac IIIEVP, CFO
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$58.8K
6,379 sh
$58.8K
Filed 01/07
Traded 01/05
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$19K
2,447 sh
$19K
Filed 24/03/05
Traded 24/03/04
Edward J. Dulac IIICFO
Sell10b5-1 planFate Therapeutics
Sell10b5-1 plan
Fate Therapeutics
FATE
$9,245
1,849 sh
$9,245
Filed 24/01/30
Traded 24/01/29
Edward J. Dulac IIICFO
SellFate Therapeutics
Sell
Fate Therapeutics
FATE
$30.7K
7,028 sh
$30.7K
Filed 24/01/10
Traded 24/01/09